Sabzevari Helen 4
4 · PRECIGEN, INC. · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Precigen (PGEN) CEO Helen Sabzevari Sells 119,250 Shares
What Happened
- Helen Sabzevari, President and CEO of Precigen, sold 119,250 shares of Precigen common stock on May 28, 2026 at $4.36 per share, generating proceeds of approximately $519,930. The sale is reported as an S (sale) and was executed as a sell-to-cover to satisfy tax withholding obligations tied to restricted stock units that vested on May 23, 2026.
Key Details
- Transaction date and price: 2026-05-28, $4.36 per share
- Shares sold / proceeds: 119,250 shares / ~$519,930
- Post-transaction holdings: Not specified in the Form 4 filing
- Footnote: Sale was a sell-to-cover to satisfy tax withholding upon RSU vesting on 2026-05-23 (Footnote F1)
- Filing date: Form 4 filed 2026-06-01 (appears after the typical two-business-day reporting window)
Context
- Sell-to-cover transactions are routine tax-related sales when restricted stock units vest and do not necessarily indicate management sentiment about the company’s prospects. Purchases by insiders tend to be more informative about bullish conviction.
Insider Transaction Report
Form 4
PRECIGEN, INC.PGEN
Sabzevari Helen
President and CEO
Transactions
- Sale
Common Stock
[F1]2026-05-28$4.36/sh−119,250$519,930→ 3,768,872 total
Footnotes (1)
- [F1]Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact|2026-06-01